<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-27T01:02:15Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/18149" metadataPrefix="mods">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/18149</identifier><datestamp>2024-09-24T13:24:02Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>Palao Utiel, Eduardo</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Sola Llano, Rebeca</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Tabero Truchado, Andrea</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Manzano, Hegoi</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Rodríguez Agarrabeitia, Antonia</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Villanueva Oroquieta, Ángeles</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>López Arbeloa, Íñigo María</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Martínez Martínez, Virginia</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Ortiz García, María Josefa</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2023-06-17T22:09:31Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2023-06-17T22:09:31Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2017-07-26</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="issn">0947-6539</mods:identifier>
   <mods:identifier type="doi">10.1002/chem.201701347</mods:identifier>
   <mods:identifier type="uri">https://hdl.handle.net/20.500.14352/18149</mods:identifier>
   <mods:identifier type="officialurl">http://dx.doi.org/10.1002/chem.201701347</mods:identifier>
   <mods:identifier type="relatedurl">http://onlinelibrary.wiley.com/wol1/doi/10.1002/chem.201701347/full</mods:identifier>
   <mods:identifier type="relatedurl">https://www.researchgate.net/publication/317190378_AcetylacetonateBODIPY-Biscyclometalated_IridiumIII_Complexes_Effective_Strategy_towards_Smarter_Fluorescent_Photosensitizer_Agents</mods:identifier>
   <mods:abstract>Biscyclometalated IrIII complexes involving boron-dipyrromethene (BODIPY)-based ancillary ligands, where the BODIPY unit is grafted to different chelating cores (acetylacetonate for Ir-1 and Ir-2, and bipyridine for Ir-3) by the BODIPY meso position, have been synthesized and characterized. Complexes with the BODIPY moiety directly grafted to acetylacetonate (Ir-1 and Ir-2) exhibit higher absorption coefficients (ϵ≈4.46×104 m−1 cm−1 and 3.38×104 m−1 cm−1 at 517 nm and 594 nm, respectively), higher moderate fluorescence emission (φfl≈0.08 and 0.22 at 528 nm and 652 nm, respectively) and, in particular, more efficient singlet oxygen generation upon visible-light irradiation (φΔ≈0.86 and 0.59, respectively) than that exhibited by Ir-3 (φΔ≈0.51, but only under UV light). Phosphorescence emission, nanosecond time-resolved transient absorption, and DFT calculations suggest that BODIPY-localized long-lived 3IL states are populated for Ir-1 and Ir-2. In vitro photodynamic therapy (PDT) activity studied for Ir-1 and Ir-2 in HeLa cells shows that such complexes are efficiently internalized into the cells, exhibiting low dark- and high photocytoxicity, even at significantly low complex concentration, making them potentially suitable as theranostic agents. © 2017 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">restricted access</mods:accessCondition>
   <mods:titleInfo>
      <mods:title>AcetylacetonateBODIPY-Biscyclometalated Iridium(III) Complexes: Effective Strategy towards Smarter Fluorescent Photosensitizer Agents</mods:title>
   </mods:titleInfo>
   <mods:genre>journal article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>